psilocybin has been researched along with Benign Neoplasms in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 14 (60.87) | 2.80 |
| Authors | Studies |
|---|---|
| Lehto, RH; Miller, M; Sender, J | 1 |
| Barnett, BS; Carlo, AD; Doblin, R; Ziegler, K | 1 |
| Ameringen, MV; Beaulieu, S; Castle, D; Frey, BN; Garel, N; Greenway, KT; Husain, MI; Kennedy, SH; Lam, RW; Lee, Y; Mansur, RB; McIntyre, RS; Milev, R; Offman, H; Parikh, SV; Ravindran, AV; Rosenblat, JD; Schaffer, A; Taylor, V; Tourjman, V; Yatham, LN | 1 |
| Hapke, E; O'Sullivan, S; Patchett-Marble, R; Tadwalkar, S | 1 |
| Agrawal, M; Ameli, R; Berger, A; Shnayder, S; Sinaii, N | 1 |
| Kooijman, NI; Kramers, C; Mulleners, WM; Reuser, A; van der Wal, SEI; Vissers, KCP; Willegers, T | 1 |
| Dalo, J; Weisman, N; White, CM | 1 |
| Agrawal, M; Emanuel, E; Richards, B; Richards, W; Roddy, K; Thambi, P | 1 |
| Beck, A; Byrne, K; Durns, T; Garland, EL; Hendrick, J; Lewis, BR; Thielking, P | 1 |
| Amit, M; Cohen, L; Ramondetta, LM; Yaniv, D | 1 |
| Ahmed, H; Arshad, T; Mushahid, H | 1 |
| Agin-Liebes, GI; Bossis, AP; Fischer, S; Grigsby, J; Guss, J; Malone, T; Mennenga, SE; Ponté, KL; Ross, S; Yalch, MM | 1 |
| Hendricks, PS; Sexton, JD; Simonsson, O | 1 |
| Ali, A; Gordon, L; Grant, J; Lowe, H; Ngwa, W; Steele, B; Toyang, N; Valentine, H | 1 |
| Hope, S; Matzo, M; Rosa, WE | 1 |
| Ross, S | 1 |
| Nutt, D | 1 |
| Agin-Liebes, G; Babb, J; Belser, A; Bossis, A; Cohen, B; Corby, P; Guss, J; Kalliontzi, K; Malone, T; Mennenga, SE; Ross, S; Schmidt, BL; Su, Z | 1 |
| Carducci, MA; Cosimano, MP; Griffiths, RR; Johnson, MW; Klinedinst, MA; Richards, BD; Richards, WA; Umbricht, A | 1 |
| Spiegel, D | 1 |
| Stix, G | 1 |
| Chopra, GS; Danforth, AL; Greer, GR; Grob, CS; Hagerty, M; Halberstadt, AL; McKay, CR | 1 |
| Macready, N | 1 |
6 review(s) available for psilocybin and Benign Neoplasms
| Article | Year |
|---|---|
The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.
Topics: Anxiety; Humans; Mental Health; Neoplasms; Psilocybin; Psychotherapy | 2022 |
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Topics: Anxiety; Canada; Depressive Disorder, Major; Hallucinogens; Humans; Neoplasms; Psilocybin | 2023 |
Are psychedelics the answer to chronic pain: A review of current literature.
Topics: Chronic Pain; Cluster Headache; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Randomized Controlled Trials as Topic | 2023 |
Psychedelics for Patients With Cancer: A Comprehensive Literature Review.
Topics: Antidepressive Agents; Anxiety; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neoplasms; Psilocybin; Randomized Controlled Trials as Topic | 2023 |
The Therapeutic Potential of Psilocybin.
Topics: Biomedical Research; Clinical Studies as Topic; Hallucinogens; Humans; Mental Disorders; Molecular Structure; Neoplasms; Psilocybin | 2021 |
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.
Topics: Anxiety; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Serotonin Antagonists; Stress, Psychological | 2018 |
3 trial(s) available for psilocybin and Benign Neoplasms
| Article | Year |
|---|---|
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Topics: Adult; Aged; Anxiety; Cross-Over Studies; Depression; Double-Blind Method; Female; Hallucinogens; Humans; Male; Middle Aged; Neoplasms; Psilocybin; Psychotherapy; Quality of Life; Surveys and Questionnaires; Young Adult | 2016 |
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Topics: Anxiety; Attitude; Cross-Over Studies; Depression; Double-Blind Method; Female; Follow-Up Studies; Hallucinogens; Humans; Male; Middle Aged; Neoplasms; Psilocybin; Quality of Life; Surveys and Questionnaires | 2016 |
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Topics: Adult; Affect; Anxiety; Double-Blind Method; Female; Follow-Up Studies; Hallucinogens; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Personality Inventory; Pilot Projects; Psilocybin; Time Factors; Treatment Outcome | 2011 |
14 other study(ies) available for psilocybin and Benign Neoplasms
| Article | Year |
|---|---|
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
Topics: Adult; Hallucinogens; Hematologic Neoplasms; Humans; Lysergic Acid Diethylamide; Neoplasms; Phenethylamines; Psilocybin | 2022 |
Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.
Topics: Agaricales; Humans; Lung Neoplasms; Neoplasms; Palliative Care; Psilocybin; Stress, Psychological | 2022 |
Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.
Topics: Depressive Disorder, Major; Hallucinogens; Humans; Neoplasms; Psilocybin; Self Report | 2023 |
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.
Topics: Depression; Depressive Disorder, Major; Humans; Neoplasms; Patients; Psilocybin | 2023 |
HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.
Topics: Depressive Disorder, Major; Humans; Neoplasms; Pilot Projects; Psilocybin; Psychotherapy, Group | 2023 |
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression.
Topics: Anxiety; Depression; Humans; Neoplasms; Psilocybin; Psychotherapy | 2023 |
UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.
Topics: Depression; Hallucinogens; Humans; Neoplasms; Psilocybin | 2023 |
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Topics: Adult; Aged; Combined Modality Therapy; Existentialism; Female; Follow-Up Studies; Hallucinogens; Humans; Male; Middle Aged; Neoplasms; Psilocybin; Psychological Distress; Psychotherapy; Self Report; Time Factors; Treatment Outcome | 2020 |
Associations between lifetime classic psychedelic use and markers of physical health.
Topics: Adult; Body Mass Index; Drug Users; Female; Hallucinogens; Health Status; Heart Diseases; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Neoplasms; Psilocybin; Self Report; Substance-Related Disorders; Surveys and Questionnaires; United States | 2021 |
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care.
Topics: Banisteriopsis; Camphanes; Drugs, Chinese Herbal; Female; Humans; Medicine, Traditional; Mescaline; Middle Aged; Neoplasms; Palliative Care; Panax notoginseng; Psilocybin; Salvia miltiorrhiza; Spiritual Therapies; Tabernaemontana | 2019 |
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.
Topics: Anxiety; Depression; Hallucinogens; Humans; Neoplasms; Psilocybin | 2016 |
Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Psychotherapy | 2016 |
Return of a problem child.
Topics: Anxiety; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin | 2009 |
Opening doors of perception: psychedelic drugs and end-of-life care.
Topics: Consciousness; Controlled Clinical Trials as Topic; Hallucinogens; Humans; Meditation; Neoplasms; Psilocybin; Spirituality; Stress, Psychological; Terminal Care; Terminally Ill; Treatment Outcome | 2012 |